⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
Pomerantz LLP Issues Important Reminder to ARS Pharmaceuticals, Inc. Investors – SPRY
accessnewswire.com
SPRY
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 – Contact Levi & Korsinsky
accessnewswire.com
SPRY
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action – Contact Levi & Korsinsky
accessnewswire.com
SPRY
Pomerantz LLP Issues Important Reminder to ARS Pharmaceuticals, Inc. Investors – SPRY
accessnewswire.com
SPRY
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities Violations – Contact Levi & Korsinsky Today
accessnewswire.com
SPRY
ROSEN, A LONGSTANDING LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY